vs
Side-by-side financial comparison of ASHLAND INC. (ASH) and Atlas Lithium Corp (ATLX), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.
ASHLAND INC. is the larger business by last-quarter revenue ($386.0M vs $42.0K, roughly 9196.4× Atlas Lithium Corp). ASHLAND INC. runs the higher net margin — -3.1% vs -17708.6%, a 17705.5% gap on every dollar of revenue. On growth, ASHLAND INC. posted the faster year-over-year revenue change (-4.7% vs -73.0%). ASHLAND INC. produced more free cash flow last quarter ($111.0M vs $-7.0M). Over the past eight quarters, ASHLAND INC.'s revenue compounded faster (-18.1% CAGR vs -55.6%).
Ashland, Inc., is an American chemical company headquartered in Wilmington, Delaware. The company began as an oil refinery in the city of Ashland, Kentucky, in 1924, before moving to Wilmington in 1994. The company has five wholly owned divisions, which include Chemical Intermediates and Solvents, composites, industrial specialties, personal and home care, pharmaceuticals, food and beverage, and agriculture. Until 2017, the company was the primary manufacturer of Valvoline.
Atlas Copco Group is a Swedish multinational industrial company. It manufactures compressors, vacuum equipment, pumps, generators, assembly tools, quality assurance equipment and other products and systems for industrial applications and mobile power generation. The products are sold in around 180 countries.
ASH vs ATLX — Head-to-Head
Income Statement — Q1 2026 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $386.0M | $42.0K |
| Net Profit | $-12.0M | $-7.4M |
| Gross Margin | 27.2% | 51.1% |
| Operating Margin | -1.6% | -18376.1% |
| Net Margin | -3.1% | -17708.6% |
| Revenue YoY | -4.7% | -73.0% |
| Net Profit YoY | 92.7% | 35.7% |
| EPS (diluted) | $-0.26 | $-0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.
| Q4 25 | $386.0M | $42.0K | ||
| Q3 25 | $477.0M | $-1 | ||
| Q2 25 | $463.0M | $43.0K | ||
| Q1 25 | $479.0M | $36.4K | ||
| Q4 24 | $405.0M | $155.6K | ||
| Q3 24 | $521.0M | $178.0K | ||
| Q2 24 | $544.0M | $202.3K | ||
| Q1 24 | $575.0M | $212.8K |
| Q4 25 | $-12.0M | $-7.4M | ||
| Q3 25 | $31.0M | $-7.0M | ||
| Q2 25 | $-742.0M | $-5.6M | ||
| Q1 25 | $31.0M | $-9.0M | ||
| Q4 24 | $-165.0M | $-11.6M | ||
| Q3 24 | $17.0M | $-9.0M | ||
| Q2 24 | $6.0M | $-9.2M | ||
| Q1 24 | $120.0M | $-13.0M |
| Q4 25 | 27.2% | 51.1% | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 28.5% | -42.4% | ||
| Q1 25 | 30.7% | -172.1% | ||
| Q4 24 | 27.4% | 13.2% | ||
| Q3 24 | 33.2% | 39.0% | ||
| Q2 24 | 34.2% | 45.0% | ||
| Q1 24 | 28.0% | 39.8% |
| Q4 25 | -1.6% | -18376.1% | ||
| Q3 25 | 12.8% | 799268600.0% | ||
| Q2 25 | -152.9% | -14241.3% | ||
| Q1 25 | 10.6% | -26969.3% | ||
| Q4 24 | -44.2% | -6980.6% | ||
| Q3 24 | 6.1% | -5767.8% | ||
| Q2 24 | -11.2% | -4719.4% | ||
| Q1 24 | 3.7% | -6195.7% |
| Q4 25 | -3.1% | -17708.6% | ||
| Q3 25 | 6.5% | 695327600.0% | ||
| Q2 25 | -160.3% | -12931.2% | ||
| Q1 25 | 6.5% | -24754.9% | ||
| Q4 24 | -40.7% | -7426.0% | ||
| Q3 24 | 3.3% | -5073.0% | ||
| Q2 24 | 1.1% | -4534.1% | ||
| Q1 24 | 20.9% | -6093.1% |
| Q4 25 | $-0.26 | $-0.33 | ||
| Q3 25 | $0.83 | $-0.35 | ||
| Q2 25 | $-16.21 | $-0.31 | ||
| Q1 25 | $0.65 | $-0.55 | ||
| Q4 24 | $-3.50 | $-0.62 | ||
| Q3 24 | $0.34 | $-0.60 | ||
| Q2 24 | $0.12 | $-0.67 | ||
| Q1 24 | $2.39 | $-1.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $304.0M | $35.9M |
| Total DebtLower is stronger | $1.4B | — |
| Stockholders' EquityBook value | $1.9B | $52.0M |
| Total Assets | $4.5B | $87.7M |
| Debt / EquityLower = less leverage | 0.74× | — |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $304.0M | $35.9M | ||
| Q3 25 | $215.0M | $21.0M | ||
| Q2 25 | $207.0M | $13.9M | ||
| Q1 25 | $168.0M | $14.0M | ||
| Q4 24 | $219.0M | $15.5M | ||
| Q3 24 | $300.0M | $22.1M | ||
| Q2 24 | $399.0M | $32.3M | ||
| Q1 24 | $439.0M | $17.5M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | — |
| Q4 25 | $1.9B | $52.0M | ||
| Q3 25 | $1.9B | $34.3M | ||
| Q2 25 | $1.9B | $25.0M | ||
| Q1 25 | $2.6B | $23.6M | ||
| Q4 24 | $2.6B | $21.3M | ||
| Q3 24 | $2.9B | $23.3M | ||
| Q2 24 | $3.0B | $27.2M | ||
| Q1 24 | $3.1B | $561.9K |
| Q4 25 | $4.5B | $87.7M | ||
| Q3 25 | $4.6B | $72.2M | ||
| Q2 25 | $4.6B | $63.3M | ||
| Q1 25 | $5.2B | $60.8M | ||
| Q4 24 | $5.2B | $57.9M | ||
| Q3 24 | $5.6B | $60.5M | ||
| Q2 24 | $5.7B | $63.2M | ||
| Q1 24 | $5.9B | $37.6M |
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 0.42× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $125.0M | $-6.8M |
| Free Cash FlowOCF − Capex | $111.0M | $-7.0M |
| FCF MarginFCF / Revenue | 28.8% | -16667.4% |
| Capex IntensityCapex / Revenue; lower = less reinvestment burden | 3.6% | 463.1% |
| Cash ConversionOCF / Net Profit; >1× = earnings back up with cash | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $200.0M | $-28.3M |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $125.0M | $-6.8M | ||
| Q3 25 | $40.0M | $-7.1M | ||
| Q2 25 | $115.0M | $-3.9M | ||
| Q1 25 | $9.0M | $-4.4M | ||
| Q4 24 | $-30.0M | $-4.6M | ||
| Q3 24 | $80.0M | $-2.9M | ||
| Q2 24 | $127.0M | $-5.2M | ||
| Q1 24 | $54.0M | $-6.1M |
| Q4 25 | $111.0M | $-7.0M | ||
| Q3 25 | $6.0M | $-8.2M | ||
| Q2 25 | $95.0M | $-5.5M | ||
| Q1 25 | $-12.0M | $-7.6M | ||
| Q4 24 | $-53.0M | $-7.8M | ||
| Q3 24 | $42.0M | $-8.1M | ||
| Q2 24 | $98.0M | $-13.3M | ||
| Q1 24 | $20.0M | $-12.0M |
| Q4 25 | 28.8% | -16667.4% | ||
| Q3 25 | 1.3% | 822801700.0% | ||
| Q2 25 | 20.5% | -12685.5% | ||
| Q1 25 | -2.5% | -20812.1% | ||
| Q4 24 | -13.1% | -5043.1% | ||
| Q3 24 | 8.1% | -4559.3% | ||
| Q2 24 | 18.0% | -6576.9% | ||
| Q1 24 | 3.5% | -5621.0% |
| Q4 25 | 3.6% | 463.1% | ||
| Q3 25 | 7.1% | -116975500.0% | ||
| Q2 25 | 4.3% | 3605.9% | ||
| Q1 25 | 4.4% | 8722.7% | ||
| Q4 24 | 5.7% | 2105.2% | ||
| Q3 24 | 7.3% | 2918.6% | ||
| Q2 24 | 5.3% | 4011.6% | ||
| Q1 24 | 5.9% | 2752.4% |
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.71× | — | ||
| Q2 24 | 21.17× | — | ||
| Q1 24 | 0.45× | — |
Financial Flow Comparison
Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.
Revenue Breakdown by Segment
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
ATLX
Segment breakdown not available.
